About Index Trending news
Analyze
Pricing
Skyline Ventures

Skyline Ventures

Work at Skyline Ventures? Add yourself to this profile

Skyline Ventures

Elsewhere

Alexa global traffic share

Investment profile

Target markets
Health Care Biotechnology

Activity

Past year's investments

Skyline Ventures participated in fewer than 3 rounds over the past year.

Latest rounds

- Dicerna Pharma: Post-IPO equity ($70M)
- Proteon Therapeutics: Venture capital (Series D) ($45M)
- SI-BONE, Inc.: Venture capital ($33M)

Main Co-investors

- TVM Capital
- Intersouth Partners
- Flagship Ventures

Total funding
$145.3M in 6 rounds from 15 investors
By Skyline Ventures
$30M Series C in Oct, 2012
Total funding
$80.6M in 4 rounds from 8 investors
By Skyline Ventures
$33M Venture capital in Apr, 2014
Total funding
$107M in 3 rounds from 22 investors
By Skyline Ventures
$45M Series D in May, 2014
Total funding
$258M in 4 rounds from 18 investors
By Skyline Ventures
$70M Post-IPO equity in Mar, 2017
Total funding
$121.6M in 3 rounds from 10 investors
By Skyline Ventures
$28M Series D in Jan, 2013
Total funding
$78.8M in 5 rounds from 16 investors
By Skyline Ventures
$26M Series D in Dec, 2013
Total funding
$60M in 2 rounds from 11 investors
By Skyline Ventures
$45M Series C in Jun, 2010
Total funding
$500k in 1 rounds from 4 investors
By Skyline Ventures
$500k Series C in Feb, 2009
Total funding
$72.3M in 2 rounds from 9 investors
By Skyline Ventures
$43.8M Series C in May, 2006
Exit Amgen Inc., Oct 2, 2008
Total funding
$35M in 1 rounds from 7 investors
By Skyline Ventures
$35M Series B in May, 2006
Exit Amgen Inc., Apr 10, 2012
Total funding
$125.5M in 4 rounds from 26 investors
By Skyline Ventures
$37M Series C in Apr, 2008

Want to see the complete list?
Go Pro!